Clinical characteristics of covid-19 patients at King Saud Medical City: a retrospective study

Main Article Content

Marwah Bin Talib
Abdullah A. Baredhwan
Khaled Alenazi
Ali Almagooshi
Abdulrehman M. Alqahtani
Sultan A. Alsobayeg
Sarah Alhazmi
Waad Awad
Ameera S. Alamri
Parameaswari P. Jaganathan
Manasik N. Abdu
Latif Ahmed Khan

Abstract

Background. COVID-19, a new viral disease caused by Corona Virus (SARS-CoV-2) was reported first by Chinese. WHO declared it a pandemic in March 2020. We saw a huge number of this illness that caused a stress on health care systems and a high proportion of mortality. World Health Organization declared it as a pandemic in March 2020. We planned this study with the objective of knowing clinical presentation, hospital management and final outcome of COVID-19 in our population and compare it with other institution who studied the disease elsewhere. Materials and methods. A retrospective study on COVID-19 patients with severe to critical illness was conducted in King Saud Medical City Riyadh. Proper permission was issued by ethical committee of King Saud Medical City. Data was collected manually as well from electronic records. Data was analyzed using standard statistical methods. A total of 689 patients that were admitted to KSMC from 1st March 2020 to 30th of June 2020. Results. More than 50 % of our patients were from Indian subcontinent (India, Pakistan and Bangladesh). Our mean age was 50 years. Females comprised 17.3 % of our patients. Common presentation was breathlessness (79 %), cough (70 %) and fever (67 %). Mean oxygen saturation on presentation was 92 %. Around sixty one percent of our patients were critical and were treated in intensive care unit. Mortality was 35 % and multi-organ failure 25 %. Although diabetes mellitus (37.3 %) and hypertension (29.5 %) were common comorbidities but it did not increase the mortality in our patients. Our mortality seems to be related to late reporting to hospital and severe disease itself. Conclusions. A retrospective study conducted at King Saud Medical city on 689 patients of severe and critical COVID-19. A high proportion were admitted to intensive care unit (60.8 %), 41 % needed invasive ventilation and 29 % required vasopressors and 14 % needed hemodialysis. Mortality of 35 % was recorded in our study. People of Indian subcontinent (Pakistani, Bangladeshi and Indians) formed more than 50 % of patients.

Article Details

How to Cite
Talib, M. B., A. A. Baredhwan, K. Alenazi, A. Almagooshi, A. M. Alqahtani, S. A. Alsobayeg, S. Alhazmi, W. Awad, A. S. Alamri, P. P. Jaganathan, M. N. Abdu, and L. A. Khan. “Clinical Characteristics of Covid-19 Patients at King Saud Medical City: A Retrospective Study”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 17, no. 1, Apr. 2021, pp. 3-10, doi:10.22141/2224-0721.17.1.2021.226424.
Section
Original Researches

References

World Health Organization. Novel Coronavirus (2019-nCoV). WHO. 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 .

Tan W, Zhao X, Ma X, et al. Notes from the Field: A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases — Wuhan, China 2019−2020. China CDC Weekly. 2020;2(4):61-62. doi:10.46234/ccdcw2020.017.

Sohrabi C, Alsafi Z, O'Neill N, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020 Apr;76:71-76. doi:10.1016/j.ijsu.2020.02.034.

Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020 Feb 22;395(10224):565-574. doi:10.1016/S0140-6736(20)30251-8.

Pal M, Berhanu G, Desalegn C, Kandi V. Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update. Cureus. 2020 Mar 26;12(3):e7423. doi:10.7759/cureus.7423.

Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi:10.1001/jama.2020.2648.

Oran DP, Topol EJ. Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review. Ann Intern Med. 2020 Sep 1;173(5):362-367. doi:10.7326/M20-3012.

Lavezzo E, Franchin E, Ciavarella C, et al; Imperial College COVID-19 Response Team. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'. Nature. 2020 Aug;584(7821):425-429. doi:10.1038/s41586-020-2488-1.

Meyerowitz-Katz G, Merone L. A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates. Int J Infect Dis. 2020 Dec;101:138-148. doi:10.1016/j.ijid.2020.09.1464.

Alsofayan YM, Althunayyan SM, Khan AA, Hakawi AM, Assiri AM. Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study. J Infect Public Health. 2020 Jul;13(7):920-925. doi:10.1016/j.jiph.2020.05.026.

COVID 19 Dashboard: Saudi Arabia. Available from: https://covid19.moh.gov.sa . Accessed: 29.11.2020.

Saudi MoH Protocol for Patients Suspected of/Confirmed with COVID-19 Supportive care and antiviral treatment of suspected or confirmed COVID-19 infection. Available from: https://covid19.cdc.gov.sa/ . Accessed: 09.12.2020.

Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475-481. doi:10.1016/S2213-2600(20)30079-5.

Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. 2020 May 21;382(21):2012-2022. doi:10.1056/NEJMoa2004500.

Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi:10.1001/jamainternmed.2020.0994.

Barry M, AlMohaya A, AlHijji A, et al. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area. J Epidemiol Glob Health. 2020 Sep;10(3):214-221. doi:10.2991/jegh.k.200806.002.

Tamara A, Tahapary DL. Obesity as a predictor for a poor prognosis of COVID-19: A systematic review. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):655-659. doi:10.1016/j.dsx.2020.05.020.

Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi:10.1001/jama.2020.1585.

Flythe JE, Assimon MM, Tugman MJ, et al; STOP-COVID Investigators. Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States. Am J Kidney Dis. 2021 Feb;77(2):190-203.e1. doi:10.1053/j.ajkd.2020.09.003.

Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020 May 26;323(20):2052-2059. doi:10.1001/jama.2020.6775.

Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020 May 12;323(18):1775-1776. doi:10.1001/jama.2020.4683.

Shabrawishi M, Al-Gethamy MM, Naser AY, et al. Clinical, radiological and therapeutic characteristics of patients with COVID-19 in Saudi Arabia. PLoS One. 2020 Aug 6;15(8):e0237130. doi:10.1371/journal.pone.0237130.

Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-1720. doi:10.1056/nejmoa2002032.